Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis.
Saved in:
| Title: | Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis. |
|---|---|
| Authors: | Fischer BA; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Khameneh HJ; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Guerra J; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Zenobi A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Ciorciari J; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Buzzago I; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Merli MS; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Said M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Ventura PMO; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Pfister A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Mattei L; Cantonal Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland., Cavalli D; Cantonal Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland., Molinari F; Cantonal Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland., Rinaldi A; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Moro SG; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Kwee I; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.; BigOmics Analytics SA, Lugano, Switzerland., Morone D; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Mosole S; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Jarrossay D; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Montanino C; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Simonelli L; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Varani L; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Radice E; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Thelen M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Di Serio C; University Centre of Statistics in the Biomedical Sciences (CUSSB), Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.; Biomedical Faculty, Università della Svizzera Italiana, Lugano, Switzerland.; Clinical Trial Unit (CTU), EOC, Locarno, Switzerland., Calabretta E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Dreval K; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada., Morin R; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.; Centre for Lymphoid Cancer, BC Cancer, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre at BC Cancer, Vancouver, British Columbia, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, British Columbia, Canada., Jauk F; Cantonal Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland.; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Frattini M; Cantonal Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland., Barizzi J; Cantonal Institute of Pathology Ente Ospedaliero Cantonale (EOC), Locarno, Switzerland., Cascione L; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Bertoni F; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland., Robbiani DF; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Rossi D; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland., Guarda G; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland. greta.guarda@irb.usi.ch. |
| Source: | Nature immunology [Nat Immunol] 2026 Jul; Vol. 27 (7), pp. 1490-1501. Date of Electronic Publication: 2026 Jun 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
